Articles

Optimizing Outcomes With Maximal Surgical Resection A long-standing controversy in the neurosurgical literature involves the efficacy of maximally resecting malignant gliomas.
Journal Article, March 2003
Hematopoietic Stem Cells and Hematopoiesis Each day the human body produces billions of new white blood cells, red blood cells, and platelets to replace blood cells lost to normal cell turnover processes as well as to illness or trauma.
Journal Article, January 2003
Nonmyeloablative Allogeneic Stem-Cell Transplantation Allogeneic Stem-Cell Transplantation.
Journal Article, January 2003
High-Dose Chemotherapy for Breast Cancer: The PEGASE Experience In the early 1990s, tremendous enthusiasm developed for the application of intensive chemotherapy in treating breast cancer.
Journal Article, January 2003
High-Dose Chemotherapy in Adult Patients With Germ Cell Tumors Approximately 80% of patients with advanced germ cell tumors (GCTs) are cured with first-line cisplatin-based chemotherapy
Journal Article, January 2003
Intense Immunosuppression and Stem-Cell Transplantation Systemic rheumatic autoimmune diseases include rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), systemic lupus erythematosus (SLE), and systemic sclerosis (SSc).
Journal Article, January 2003
Risk for Hereditary Breast and Ovarian Cancer The American Cancer Society estimates that over 200,000 women will be diagnosed with breast cancer in the United States in 2002, and nearly 40,000 will die of the disease.
Journal Article, November 2002
Ductal Lavage for Breast Cancer Risk Assessment Breast cancer risk reduction strategies are currently available in the form of medical and surgical interventions, all of which are associated with possible life-threatening complications.
Journal Article, November 2002
The Use of Bisphosphonates in Patients With Breast Cancer Breast cancer incidence in the United States in 2002 is expected to account for approximately 30% of all new cancer cases among women, and mortality due to breast cancer is estimated to comprise 15% of all cancer-related deaths.
Journal Article, November 2002
Aromatase Inhibitors in Breast Cancer: An Update Endocrine therapy is the oldest, safest, and best-established systemic treatment for breast cancer, with utility in all stages of disease.
Journal Article, November 2002
Trastuzumab Use in Breast Cancer: Clinical Issues The human epidermal growth factor receptor 2 (HER2), also known as c-erbB-2 and HER2/neu, promotes cell growth and tumor development.
Journal Article, November 2002
Microsurgery in Carcinomas of Oral Cavity, Pharynx and Larynx The word laser is an acronym for light amplification by stimulated emission of radiation.
Journal Article, October 2002
Molecular Genetics of Head and Neck Cancer Genetic abnormalities in head and neck squamous cell cancer have been studied extensively, and frequent changes have been found.
Journal Article, September 2002
Treatment of Locally Advanced Head and Neck Cancer The mode of treatment of patients with squamous cell carcinoma of the head and neck depends on the site and stage of the disease and on the overall health status of the patient.
Journal Article, September 2002
Oropharyngeal Dysphagia in Head and Neck Cancer Dysphagia, derived from the Greek phagein, meaning "to eat," is a common symptom of head and neck cancer and can be an unfortunate sequelae of its treatment.
Journal Article, September 2002
Ethical Considerations in the Treatment of Head and Neck Cancer Ethical considerations in the treatment of head and neck cancer comprise a relatively unexplored area within the context of overall cancer care.
Journal Article, September 2002
Evaluation and Management of Adrenal Masses The presence and importance of the adrenal glands as well as their physiology were initially described more than 500 years ago.
Journal Article, August 2002
Controversies of Androgen Deprivation for Prostate Cancer Conventional management of non-organ-confined, recurrent or metastatic prostate cancer continues to evolve due to earlier diagnosis of recurrent disease with prostate-specific antigen (PSA) monitoring, new medications such as luteinizing hormone-releasing hormone (LHRH) analogs, LHRH antagonists, and androgen antagonists.
Journal Article, August 2002
Surgical Management of Bladder Carcinoma Despite advances in medical oncology, radiation therapy, and molecular and cell biology, surgery continues to be the mainstay of the management of bladder cancer.
Journal Article, August 2002
Retroperitoneal Lymph Node Dissection and Testicular Cancer It is well recognized that cisplatin-based chemotherapy is highly effective in the treatment of metastatic testicular cancer.
Journal Article, August 2002

Articles

About

Membership

Apps

WebMD Network

Editions

Articles

Find Us On

About

Membership

Apps

WebMD Network

Editions